Cooper Health System MD Anderson Cancer Center at Cooper — Camden, New Jersey

Cooper Health System MD Anderson Cancer Center at Cooper is a clinical research site located in Camden, New Jersey, United States 08103.

Crixeo Health Trust Score: 56/100 (POOR). This profile has not yet been claimed by the site owner.

Cooper Health System MD Anderson Cancer Center at Cooper has participated in 2 clinical trials with 2 currently active.

Therapeutic areas: Relapsed or Refractory Multiple Myeloma, Bladder Cancer.

Sponsors: Janssen Research & Development, LLC.

Sponsor Feasibility Report

Trust Score: 56/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Cooper Health System MD Anderson Cancer Center at Cooper?

Cooper Health System MD Anderson Cancer Center at Cooper has a Crixeo Trust Score of 56/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Cooper Health System MD Anderson Cancer Center at Cooper conducted?

Cooper Health System MD Anderson Cancer Center at Cooper has 2 clinical trials on record, with 2 currently active. Their work covers Relapsed or Refractory Multiple Myeloma, Bladder Cancer.

Is Cooper Health System MD Anderson Cancer Center at Cooper accredited by Crixeo Health?

Cooper Health System MD Anderson Cancer Center at Cooper has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Cooper Health System MD Anderson Cancer Center at Cooper?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.